glp 1 and stroke GLP-1 receptor agonists in prevention: a narrative review on emerging therapeutic frontiers Stroke Prevention Guideline Adds Recs

This study found that the hazard of NAION was 3.24 times higher in individuals exposed to the GLP-1R agonists compared with those who were not, after adjusting for confounders

What I love most is that it works with my body, not against it

Prioritise Sleep: Lack of sleep can hinder your appetite-regulating hormones

The SURMOUNT-1 final results at 72 weeks showed mean weight loss of: 5 mg dose: 16.0 percent of body weight 10 mg dose: 21.4 percent of body weight 15 mg dose: 22.5 percent of body weight For context, 22.5 percent of 250 pounds is 56 pounds

In a parallel clinical cohort of 47,324 patients, GLP-1 receptor agonist use was associated with lower inflammatory biomarkers and fewer MACE events, with the benefits persisting in subgroups stratified by BMI or HbA1c

consistent daily use is recommended